Brainstorm Cell Therapeutics  logo
Brainstorm Cell Therapeutics BCLI
$ 2.26 8.73%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Brainstorm Cell Therapeutics P/E Ratio 2011-2024 | BCLI

Annual P/E Ratio Brainstorm Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.85 -2.75 -5.92 -5.92 -3.79 -5.28 -13.7 -10.3 -5.36 -5.9 -8.88 -9.23 -6.74

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.85 -13.7 -6.58